"Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereo" by Daniel A. Lawrence, Cory Emal et al.
 

Document Type

Patent

Date of Patent

8-1-2017

Abstract

The invention relates to plasminogen activator-I (PAI-1) inhibitor compounds and uses thereof in the treatment of any disease or disorder associated with elevated PAI-1. The invention includes, but is not limited to, the use of such compounds to prevent or reduce thrombosis and fibrosis, to promote thrombolysis, and to modulate lipid metabolism and treat diseases or disorders associated with elevated PAI-1, cholesterol, or lipid levels.

Original Assignee(s)

The Regents of the University of Michigan ; Eastern Michigan University

Comments

C. Emal is a faculty member in EMU's Department of Chemistry.

*G. Abernathy is an EMU student.

For current information about this patent, including the availability of Certificates of Correction, visit the United States Patent and Trademark Office's free, publicly accessible database: Patent Public Search - https://www.uspto.gov/patents/search/patent-public-search.

Patent Number

US 9,718,760

Share

COinS